Welcome to LookChem.com Sign In|Join Free

CAS

  • or

30339-30-1

Post Buying Request

30339-30-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

30339-30-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 30339-30-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,0,3,3 and 9 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 30339-30:
(7*3)+(6*0)+(5*3)+(4*3)+(3*9)+(2*3)+(1*0)=81
81 % 10 = 1
So 30339-30-1 is a valid CAS Registry Number.

30339-30-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (P1118)  (S)-1-Phenyl-2-(p-tolyl)ethylamine  >98.0%(GC)(T)

  • 30339-30-1

  • 5g

  • 1,290.00CNY

  • Detail
  • TCI America

  • (P1118)  (S)-1-Phenyl-2-(p-tolyl)ethylamine  >98.0%(GC)(T)

  • 30339-30-1

  • 25g

  • 3,850.00CNY

  • Detail

30339-30-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name (1S)-2-(4-methylphenyl)-1-phenylethanamine

1.2 Other means of identification

Product number -
Other names (S)-1-Phenyl-2-(P-Tolyl)Ethyla E

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:30339-30-1 SDS

30339-30-1Synthetic route

(1R,2S)-norephedrine
492-41-1

(1R,2S)-norephedrine

1-Phenyl-2-p-tolyl-ethanone O-benzyl-oxime
113683-85-5, 136534-11-7

1-Phenyl-2-p-tolyl-ethanone O-benzyl-oxime

(S)-2-(4-methylphenyl)-1-phenylethylamine
30339-30-1

(S)-2-(4-methylphenyl)-1-phenylethylamine

Conditions
ConditionsYield
With borane In tetrahydrofuran at 20℃;82%
(1R,2S)-norephedrine
492-41-1

(1R,2S)-norephedrine

1-Phenyl-2-p-tolyl-ethanone O-octyl-oxime
123982-65-0

1-Phenyl-2-p-tolyl-ethanone O-octyl-oxime

(S)-2-(4-methylphenyl)-1-phenylethylamine
30339-30-1

(S)-2-(4-methylphenyl)-1-phenylethylamine

Conditions
ConditionsYield
With borane In tetrahydrofuran at 20℃;64%
(1R,2S)-norephedrine
492-41-1

(1R,2S)-norephedrine

phenyl p-tolylmethyl ketone O-methyloxime
111630-13-8

phenyl p-tolylmethyl ketone O-methyloxime

(S)-2-(4-methylphenyl)-1-phenylethylamine
30339-30-1

(S)-2-(4-methylphenyl)-1-phenylethylamine

Conditions
ConditionsYield
With borane In tetrahydrofuran at 20℃;64%
1-phenyl-2-(p-tolyl)ethylamine
30275-30-0

1-phenyl-2-(p-tolyl)ethylamine

A

(S)-2-(4-methylphenyl)-1-phenylethylamine
30339-30-1

(S)-2-(4-methylphenyl)-1-phenylethylamine

B

(R)-1-phenyl-(2-p-tolyl)ethylamine
30339-32-3

(R)-1-phenyl-(2-p-tolyl)ethylamine

Conditions
ConditionsYield
A 36%
B n/a
A n/a
B 16%
Stage #1: 1-phenyl-2-(p-tolyl)ethylamine With (R)-(2,2-Me2-1,3-dioxa-c-pentan-3-yl)methyl monophthalate In water; isopropyl alcohol at 20℃; for 4h;
Stage #2: With sulfuric acid In ethyl acetate
A 600 mg
B n/a
With chiral stationary phase including isopropyl-functionalized CF6 In methanol; acetic acid; triethylamine; acetonitrile at 20℃; Purification / work up;
(1R,2S)-norephedrine
492-41-1

(1R,2S)-norephedrine

C18H23NOSi
123982-67-2

C18H23NOSi

(S)-2-(4-methylphenyl)-1-phenylethylamine
30339-30-1

(S)-2-(4-methylphenyl)-1-phenylethylamine

Conditions
ConditionsYield
With borane In tetrahydrofuran at 20℃; Yield given;
(S)-3-(benzo[1,3]dioxol-5-yl)-2-methylpropionate (S)-1-phenyl-2-(p-tolyl)ethylammonium
1254780-66-9

(S)-3-(benzo[1,3]dioxol-5-yl)-2-methylpropionate (S)-1-phenyl-2-(p-tolyl)ethylammonium

(S)-2-(4-methylphenyl)-1-phenylethylamine
30339-30-1

(S)-2-(4-methylphenyl)-1-phenylethylamine

Conditions
ConditionsYield
With sodium hydroxide In water; toluene at 25℃; for 0.5h; pH=12;
S-2-pyridyl 3-cyanoandrosta-3,5-diene-17β-thiocarboxylate
153002-83-6

S-2-pyridyl 3-cyanoandrosta-3,5-diene-17β-thiocarboxylate

(S)-2-(4-methylphenyl)-1-phenylethylamine
30339-30-1

(S)-2-(4-methylphenyl)-1-phenylethylamine

N-[(1S)-2-(4-methylphenyl)-1-phenylethyl]-3-cyanoandrosta-3,5-diene-17β-carboxamide

N-[(1S)-2-(4-methylphenyl)-1-phenylethyl]-3-cyanoandrosta-3,5-diene-17β-carboxamide

Conditions
ConditionsYield
77%
DL-3-(N-formylamino)-3-phenylpropionic acid
126575-05-1

DL-3-(N-formylamino)-3-phenylpropionic acid

(S)-2-(4-methylphenyl)-1-phenylethylamine
30339-30-1

(S)-2-(4-methylphenyl)-1-phenylethylamine

C10H11NO3*C15H17N

C10H11NO3*C15H17N

Conditions
ConditionsYield
In methanol37.9%
ethyl 1-formylcyclopropane-1-carboxylate
33329-70-3

ethyl 1-formylcyclopropane-1-carboxylate

(S)-2-(4-methylphenyl)-1-phenylethylamine
30339-30-1

(S)-2-(4-methylphenyl)-1-phenylethylamine

1-[(RS)-1-Cyano-[(S)-1-phenyl-2-p-tolylethylamino]methyl]-1-ethoxycarbonylcyclopropane

1-[(RS)-1-Cyano-[(S)-1-phenyl-2-p-tolylethylamino]methyl]-1-ethoxycarbonylcyclopropane

Conditions
ConditionsYield
With hydrogenchloride In (2S)-N-methyl-1-phenylpropan-2-amine hydrate; ethanol; water251 mg (67%)
p-toluenesulfonate monohydrate

p-toluenesulfonate monohydrate

(S)-2-(4-methylphenyl)-1-phenylethylamine
30339-30-1

(S)-2-(4-methylphenyl)-1-phenylethylamine

1,1-cyclopropanedicarboxaldehyde
136476-41-0

1,1-cyclopropanedicarboxaldehyde

orthoformic acid triethyl ester
122-51-0

orthoformic acid triethyl ester

A

(2R)-2-[1-(diethoxymethyl)cyclopropyl]-2-{[(1S)-1-phenyl-2-(p-tolyl)ethyl]amino}acetonitrile

(2R)-2-[1-(diethoxymethyl)cyclopropyl]-2-{[(1S)-1-phenyl-2-(p-tolyl)ethyl]amino}acetonitrile

B

(2S)-2-[1-(diethoxymethyl)cyclopropyl]-2-{[(1S)-1-phenyl-2-(p-tolyl)ethyl]amino}acetonitrile

(2S)-2-[1-(diethoxymethyl)cyclopropyl]-2-{[(1S)-1-phenyl-2-(p-tolyl)ethyl]amino}acetonitrile

Conditions
ConditionsYield
With sodium hydrogencarbonate; sodium hydrogensulfite In ethanol; water; toluene
(S)-2-(4-methylphenyl)-1-phenylethylamine
30339-30-1

(S)-2-(4-methylphenyl)-1-phenylethylamine

1,1-cyclopropanedicarboxaldehyde
136476-41-0

1,1-cyclopropanedicarboxaldehyde

orthoformic acid triethyl ester
122-51-0

orthoformic acid triethyl ester

A

(2R)-2-[1-(diethoxymethyl)cyclopropyl]-2-{[(1S)-1-phenyl-2-(p-tolyl)ethyl]amino}acetonitrile

(2R)-2-[1-(diethoxymethyl)cyclopropyl]-2-{[(1S)-1-phenyl-2-(p-tolyl)ethyl]amino}acetonitrile

B

(2S)-2-[1-(diethoxymethyl)cyclopropyl]-2-{[(1S)-1-phenyl-2-(p-tolyl)ethyl]amino}acetonitrile

(2S)-2-[1-(diethoxymethyl)cyclopropyl]-2-{[(1S)-1-phenyl-2-(p-tolyl)ethyl]amino}acetonitrile

Conditions
ConditionsYield
Stage #1: 1,1-cyclopropanedicarboxaldehyde; orthoformic acid triethyl ester With ethanol; toluene-4-sulfonic acid In toluene at 0 - 40℃; for 1h;
Stage #2: (S)-2-(4-methylphenyl)-1-phenylethylamine With sodium hydrogencarbonate In water; toluene at 0℃; for 0.5h;
Stage #3: With potassium cyanide; sodium hydrogensulfite In water; toluene at 50℃; for 2h;
3-(3,4-methylenedioxyphenyl)-2-methylpropionic acid
77269-66-0

3-(3,4-methylenedioxyphenyl)-2-methylpropionic acid

(S)-2-(4-methylphenyl)-1-phenylethylamine
30339-30-1

(S)-2-(4-methylphenyl)-1-phenylethylamine

A

(S)-3-(benzo[1,3]dioxol-5-yl)-2-methylpropionate (S)-1-phenyl-2-(p-tolyl)ethylammonium
1254780-66-9

(S)-3-(benzo[1,3]dioxol-5-yl)-2-methylpropionate (S)-1-phenyl-2-(p-tolyl)ethylammonium

B

(R)-3-(benzo[1,3]dioxol-5-yl)-2-methylpropionate (S)-1-phenyl-2-(p-tolyl)ethylammonium

(R)-3-(benzo[1,3]dioxol-5-yl)-2-methylpropionate (S)-1-phenyl-2-(p-tolyl)ethylammonium

Conditions
ConditionsYield
In methanol; isopropyl alcohol at 20 - 70℃; for 4.5h;
aquabis(dimethylglyoximato)[(racemic)-1-(ethoxycarbonyl)ethyl]cobalt(III)

aquabis(dimethylglyoximato)[(racemic)-1-(ethoxycarbonyl)ethyl]cobalt(III)

(S)-2-(4-methylphenyl)-1-phenylethylamine
30339-30-1

(S)-2-(4-methylphenyl)-1-phenylethylamine

bis(dimethylglyoximato)[(S)-1-(ethoxycarbonyl)ethyl][(S)-1-phenyl-2-(p-tolyl)ethylamine]cobalt(III)

bis(dimethylglyoximato)[(S)-1-(ethoxycarbonyl)ethyl][(S)-1-phenyl-2-(p-tolyl)ethylamine]cobalt(III)

Conditions
ConditionsYield
In methanol; water Co complex dissolved in aq. MeOH; ligand added; stirred for 1 h; recrystd. from aq. MeOH; Co complex with (S)-(ethoxycarbonyl)ethyl ligand obtained;
(S)-2-(4-methylphenyl)-1-phenylethylamine
30339-30-1

(S)-2-(4-methylphenyl)-1-phenylethylamine

(S)-1-((R)-1-(tert-butoxycarbonyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxylic acid
87603-13-2

(S)-1-((R)-1-(tert-butoxycarbonyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxylic acid

C30H39N3O4

C30H39N3O4

Conditions
ConditionsYield
With 1-hydroxybenzotriazol-hydrate; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 5h;
2,2'-dihydroxybenzil
85-26-7

2,2'-dihydroxybenzil

(S)-2-(4-methylphenyl)-1-phenylethylamine
30339-30-1

(S)-2-(4-methylphenyl)-1-phenylethylamine

C44H40N2O2

C44H40N2O2

C44H40N2O2

C44H40N2O2

Conditions
ConditionsYield
In ethanol at 80℃; for 6h; diastereoselective reaction;A n/a
B n/a
(S)-2-(4-methylphenyl)-1-phenylethylamine
30339-30-1

(S)-2-(4-methylphenyl)-1-phenylethylamine

(S)-(6-methyl-2-phenylindolin-1-yl)(pyridin-2-yl)methanone

(S)-(6-methyl-2-phenylindolin-1-yl)(pyridin-2-yl)methanone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dmap; triethylamine / dichloromethane / 24 h / 20 °C / Inert atmosphere
2: copper diacetate / N,N-dimethyl-formamide / 0.67 h / 200 °C / Microwave irradiation
View Scheme
2-picolinoyl chloride hydrochloride
39901-94-5

2-picolinoyl chloride hydrochloride

(S)-2-(4-methylphenyl)-1-phenylethylamine
30339-30-1

(S)-2-(4-methylphenyl)-1-phenylethylamine

C21H20N2O

C21H20N2O

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane at 20℃; for 24h; Inert atmosphere;

30339-30-1Relevant articles and documents

Resolution of 1-phenyl-2-(p-tolyl)ethylamine via diastereomeric salt formation

Pallavicini, Marco,Bolchi, Cristiano,Moroni, Barbara,Valoti, Ermanno,Piccolo, Oreste

, p. 2247 - 2251 (2003)

(S)-1-Phenyl-2-(p-tolyl)ethylamine (S)-1, used for the industrial scale resolution of chrysanthemic acids, was obtained via resolution of the racemate with the hemiphthalate of (S)-isopropylidene glycerol (R)-2. The maximum experimental efficiency [69% yield and >99% e.e. of (S)-1] was achieved by a simple precipitation of (S)-1·(R)-2 from the solution of the 1:1 diastereomeric salt mixture in 93/7 isopropanol/water at saturation of the more soluble (R)-1·(R)-2 salt. Such an experimental efficiency was consistent with 0.79 maximum theoretical resolvability, derived from the solubilities of the two diastereomeric salts, and with DSC data, which indicated that the (S)-1·(R)-2/(R)-1·(R)-2 system is a binary mixture exhibiting an eutectic with composition approximately corresponding to a 0.2 molar ratio of (S)-1·(R)-2.

COMPOSITIONS AND METHODS FOR CYCLOFRUCTANS AS SEPARATION AGENTS

-

Page/Page column 45-49; 63, (2010/12/31)

The present invention relates to derivatized cyclofructan compounds, compositions comprising derivatized cyclofructan compounds, and methods of using compositions comprising derivatized cyclofructan compounds for chromatographic separations of chemical species, including enantiomers. Said compositions may comprise a solid support and/or polymers comprising derivatized cyclofructan compounds.

Synthesis of enantiomerically pure amino-substituted fused bicyclic rings

-

, (2008/06/13)

This invention describes various processes for synthesis and resolution of racemic amino-substituted fused bicyclic ring systems. One process utilizes selective hydrogenation of an amino-substituted fused bicyclic aromatic ring system. An alternative process prepares the racemic amino-substituted fused bicyclic ring system via nitrosation. In addition, the present invention describes the enzymatic resolution of a racemic mixture to produce the (R)- and (S)-forms of amino-substituted fused bicyclic rings as well as a racemization process to recycle the unpreferred enantioner. Further provided by this invention is an asymmetric synthesis of the (R)- or (S)-enantiomer of primary amino-substituted fused bicyclic ring systems.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 30339-30-1